How Does Clover Health Company Actually Work?

Clover Health sells Medicare Advantage insurance plans (HMO and MAPD options) that combine coverage, care coordination, and telemedicine. The offering centers on Clover Assistant, a clinical decision-support platform that surfaces real-time prompts to primary care clinicians to close care gaps and lower utilization.

Clover Health packages its internal analytics and AI as a software-licensing product under Counterpart Health, selling clinical AI, risk-detection algorithms, and care-management workflows to other payers and provider groups as SaaS.

Clover Health serves Medicare-eligible seniors and dual-eligible beneficiaries seeking managed Medicare Advantage plans. Counterpart Health targets payers, provider networks, and value-based care organizations that need clinical AI and population-health tooling.

Members receive coordinated primary care, reduced hospitalizations, and integrated telemedicine; Clover reports quality-driven savings that help sustain premiums and benefits. Buyers of Counterpart Health get faster deployment of clinical prompts, risk stratification, and measurable reductions in avoidable utilization.

Customers pick Clover Health for its blend of Medicare Advantage coverage plus an operational clinical AI layer that actively guides primary care. Insurers and providers buy Counterpart Health because it converts proven, in-market algorithms into licensed software without rebuilding core analytics.

For fiscal 2025, Clover Health reported approximately $4.1 billion in revenue and served about 200,000 Medicare Advantage members nationwide, while Counterpart Health achieved initial commercial contracts contributing roughly $80 million in ARR-equivalent bookings, per company disclosures. Enrollment growth concentrated in nine states, and medical-loss ratio improvements reduced claim costs by an estimated 5-8 percentage points year-over-year in core markets.

Most revenue comes from Medicare Advantage premiums and risk-adjusted payments from the Centers for Medicare & Medicaid Services (CMS), which reimburse per-enrollee monthly amounts adjusted for patient risk and utilization.

Counterpart Health licenses clinical technology and analytics to provider partners and payers, creating a recurring, high-margin stream that complements insurance operations and scales independent of member headcount.

Insurance income is realized via per-member-per-month (PMPM) premiums and CMS capitation with risk adjustments; Counterpart Health uses subscription and licensing fees, often tied to deployment scale or usage tiers.

Revenue depends on enrolled member months, risk score capture, and CMS payment updates (for example, a 2026 CMS payment increase is expected to benefit Medicare Advantage plans); technology monetization growth matters for margin expansion.

Clover Health PPO plans ranked number one nationally on HEDIS clinical quality measures for the 2026 plan year, which supports pricing, retention, and provider collaboration. High clinical scores translate into better CMS Star positioning and marketing credibility for Clover Health Medicare Advantage enrollment.

The move toward an asset-light Counterpart Health model reduces capital intensity for geographic expansion and lowers balance-sheet risk, enabling faster market entry and leveraging Clover Health technology platform and data analytics without heavy underwriting capital.

The model relies heavily on CMS Star Ratings for bonus payments, enrollment growth, and marketing differentiation; any downgrade materially impacts revenue and margins. Regulatory scrutiny and historical investigations add execution risk tied to public payor relationships and Clover Health fraud investigations and regulatory history.

Customer economics are mixed: in early 2025 new members averaged a loss of -$110 per member per month, while returning members produced profit of $217 PMPM. High acquisition costs and the marketing intensity of Medicare Advantage enrollment processes make scaling expensive.